Form 4: Mineralys Therapeutics' Chief Medical Officer Exercises Stock Options
SEC Form 4 Filing
David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics, Inc., reports exercising stock options at prices of $0.54 and $1.08, resulting in the acquisition of 11,366 shares of common stock.
Summary
- David Malcom Rodman, the Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS), filed a Form 4 with the SEC.
- The filing reports the exercise of stock options on April 11, 2024, and April 12, 2024.
- On April 11, 2024, Rodman exercised options to acquire 5,017 shares of common stock at a price of $0.54 per share.
- On April 12, 2024, Rodman exercised options to acquire 6,349 shares of common stock at a price of $1.08 per share.
- Following these transactions, Rodman directly owns 66,997 shares of Mineralys Therapeutics.
- The filing also corrects rounding errors in the exercise prices of the stock options as originally reported in a previous Form 3.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock option exercises, indicating neutral sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, like the Chief Medical Officer, trade in their company's stock; this provides transparency to the market.
Stakeholder Impact
- The transaction increases the insider ownership stake, which could be viewed positively by shareholders.
Key Dates
| Date | Description |
|---|---|
| 2022-03-12 | 25% of the shares underlying one stock option vested. |
| 2023-02-09 | Date of Reporting Person's Form 3 filing. |
| 2023-07-12 | 25% of the shares underlying another stock option vested. |
| 2024-04-11 | Rodman exercised stock options to acquire 5,017 shares at $0.54. |
| 2024-04-12 | Rodman exercised stock options to acquire 6,349 shares at $1.08. |
| 2024-04-15 | Date of signature on the Form 4 filing. |
| 2031-03-11 | Expiration date of one stock option. |
| 2031-07-11 | Expiration date of another stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.